FDG PET is increasingly performed in patients with differentiated thyroid cancer who present
with elevated human thyroglobulin (hTG) levels and negative 131I scan. The aim of this …

Background Exact localization of recurrent iodine-negative thyroid cancer is mandatory,
since surgery is the only curative therapy option in patients with iodine-negative tumor …

18F-FDG PET has been shown to effectively detect differentiated thyroid carcinoma (DTC)
metastases with impaired iodine-trapping ability. This article evaluates the potential …

Aims This study aimed (a) to determine the clinical and histopathologic factors that are
related to FDG avidity in the recurrence/metastases of patients with differentiated thyroid …

Aim This study aimed to investigate the correlation of 18 F-FDG PET/CT findings with
histopathological results in defining the recurrence of the disease in patients with …

PET using 18F-FDG has been shown to effectively detect various types of cancer by their
increased glucose metabolism. The aim of this study was to evaluate the use of coregistered …

Purpose Advanced tumour stage and initial metastases are associated with reduced general
and tumour-free survival in patients with differentiated thyroid carcinoma. Optimal initial …

Abstract Purpose 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a
well-established method in the follow-up of patients with differentiated thyroid carcinoma …

Purpose: The aim was to evaluate the incremental diagnostic rate of F-18 fluoro-
fluorodeoxygulose positron emission tomography/computed tomography (F-18 FDG …

Background: Patients with differentiated thyroid cancer (DTC) who have a suspicious
recurrent or persistent disease based on an elevated serum thyroglobulin (Tg) or Tg …